Acurion
Acurion is revolutionizing frontline cancer care by equipping oncologists with critical genomic activity insights to get cancer patients onto the right treatments faster.
The company's mission is to accelerate the translation of its life-saving AI technology into the clinical arena to make a real, immediate and profound difference in therapy for patients worldwide.
OncoGaze™ is Acurion’s proprietary diagnostic platform that transforms routine pathology slides into powerful genomic insights—detecting critical biomarkers like HRD with high accuracy and unprecedented speed.
Built by oncologists and computational pathologists, OncoGaze™ integrates seamlessly into clinical workflows to support earlier, more informed treatment decisions in oncology.